OceansBio co.,ltd. (XKON:332190)

OceansBio co.,ltd. Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022
Revenue Revenue Growth	125.65	125.65	16.89
Revenue Growth	-	643.92%	-
Gross Profit Gross Profit Growth	89.11	89.11	16.89
Operating Income Operating Income Growth	-1,862	-1,862	-1,002
Net Income Net Income Growth	-1,013	-1,013	-554.1
Earnings Per Share EPS Growth	-686.00	-686.00	-375.00
EPS Growth	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022
Cash & Investments Cash & Investments Growth	489.18	489.18	830.24
Total Debt Total Debt Growth	960	960	860
Net Cash (Debt) Net Cash Growth	-470.82	-470.82	-29.76
Net Cash Growth	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-318.68	-318.68	-20.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-809.35	-809.35	-420.92
Capital Expenditures CapEx Growth	-20.03	-20.03	-192.54
Free Cash Flow Free Cash Flow Growth	-829.39	-829.39	-613.46
Free Cash Flow Growth	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022
Gross Margin	70.92%	70.92%	100.00%
Operating Margin	-1482.09%	-1482.09%	-5934.56%
Pretax Margin	-806.63%	-806.63%	-3280.74%
Profit Margin	-806.63%	-806.63%	-3280.74%
FCF Margin	-660.10%	-660.10%	-3632.14%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Jul 30, 2026

Data Sources Report a data error